BRICANYL TAB 5 MG DIN 00335363
Health Canada record
| Active ingredient(s) | TERBUTALINE SULFATE 5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | R03CC03 TERBUTALINE |
| Original market date | 31-Dec-1975 |
| Current status date | 23-Jul-2001 |
| Source | Health Canada DPD |
Establishment licence of the holder
AstraZeneca Canada Inc. — licence 100421, currently licensed, last inspection rating C (2023-06-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TERBUTALINE SULFATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00786616 | BRICANYL TURBUHALER | ASTRAZENECA CANADA INC | Powder | TERBUTALINE SULFATE 0.5 MG | Marketed |
| 00335355 | BRICANYL TAB 2.5 MG | ASTRAZENECA CANADA INC | Tablet | TERBUTALINE SULFATE 2.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 1544 | 2000-05-01 | New Drug Submission (NDS) |
International API supply for TERBUTALINE SULFATE
1 valid EDQM Certificates of Suitability from 1 holders. 2 active FDA Drug Master Files.
Request a quote for BRICANYL TAB 5 MG